Atossa to Participate in Noble Capital Markets Emerging Growth Healthcare Conference

Core Viewpoint - Atossa Therapeutics, Inc. is actively engaging with investors through a presentation at the Noble Capital Markets Emerging Growth Healthcare Conference, highlighting its focus on innovative treatments for breast cancer [1][2] Company Overview - Atossa Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing innovative medicines targeting significant unmet medical needs in oncology, particularly breast cancer [2] - The company is focusing on (Z)-endoxifen as a potential treatment and preventive measure for breast cancer [2] Event Details - CEO Steven Quay will present at the conference on April 17, 2024, at 9:00 am ET, with a virtual format available for attendees [1] - The presentation will be accessible for 90 days post-event on Atossa's investor relations page and Channelchek [1]